113 related articles for article (PubMed ID: 19248825)
1. Ischemic preconditioning maintains cardioprotection in aging normotensive and spontaneously hypertensive rats.
Dai W; Simkhovich BZ; Kloner RA
Exp Gerontol; 2009 May; 44(5):344-9. PubMed ID: 19248825
[TBL] [Abstract][Full Text] [Related]
2. Ischemic preconditioning is lost in aging hypertensive rat heart: independent effects of aging and longstanding hypertension.
Ebrahim Z; Yellon DM; Baxter GF
Exp Gerontol; 2007 Aug; 42(8):807-14. PubMed ID: 17532161
[TBL] [Abstract][Full Text] [Related]
3. Cardiac-specific effects of parathyroid hormone-related peptide: modification by aging and hypertension.
Ross G; Schlüter KD
Cardiovasc Res; 2005 May; 66(2):334-44. PubMed ID: 15820202
[TBL] [Abstract][Full Text] [Related]
4. Remote preconditioning by infrarenal aortic occlusion is operative via delta1-opioid receptors and free radicals in vivo in the rat heart.
Weinbrenner C; Schulze F; Sárváry L; Strasser RH
Cardiovasc Res; 2004 Feb; 61(3):591-9. PubMed ID: 14962489
[TBL] [Abstract][Full Text] [Related]
5. Age-related increase in sensitivity for ischemic ATP breakdown in hypertrophic hearts of SHR normalized by enalapril.
Schoemaker RG; Leenen FH; Harmsen E
J Mol Cell Cardiol; 1994 May; 26(5):649-60. PubMed ID: 8072019
[TBL] [Abstract][Full Text] [Related]
6. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning.
Serejo FC; Rodrigues LF; da Silva Tavares KC; de Carvalho AC; Nascimento JH
J Cardiovasc Pharmacol; 2007 Apr; 49(4):214-20. PubMed ID: 17438406
[TBL] [Abstract][Full Text] [Related]
7. Duration and reinstatement of myocardial protection against infarction by ischemic preconditioning in open chest dogs.
Schwartz LM; Sebbag L; Jennings RB; Reimer KA
J Mol Cell Cardiol; 2001 Sep; 33(9):1561-70. PubMed ID: 11549337
[TBL] [Abstract][Full Text] [Related]
8. [A treatment with rosuvastatin induced a reduction of arterial pressure and a decrease of oxidative stress in spontaneously hypertensive rats].
Sicard P; Lauzier B; Oudot A; Busseuil D; Collin B; Duvillard L; Moreau D; Vergely C; Rochette L
Arch Mal Coeur Vaiss; 2005; 98(7-8):804-8. PubMed ID: 16220751
[TBL] [Abstract][Full Text] [Related]
9. Participation of mitochondrial permeability transition pore in the effects of ischemic preconditioning in hypertrophied hearts: role of NO and mitoKATP.
Fantinelli JC; Pérez Núñez IA; González Arbeláez LF; Schinella GR; Mosca SM
Int J Cardiol; 2013 Jun; 166(1):173-80. PubMed ID: 22078400
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of Isoflurane Preconditioning-Induced Acute Cardioprotection in Hypertensive Hypertrophied Hearts.
Chen CH; Wu CW; Shih CD; Lien WH; Huang SL; Huang CC
J Cardiothorac Vasc Anesth; 2016 Oct; 30(5):1317-23. PubMed ID: 27474329
[TBL] [Abstract][Full Text] [Related]
11. Bradykinin protects against infarction but does not mediate ischemic preconditioning in the isolated rat heart.
Bugge E; Ytrehus K
J Mol Cell Cardiol; 1996 Dec; 28(12):2333-41. PubMed ID: 9004150
[TBL] [Abstract][Full Text] [Related]
12. Ischemic preconditioning: infarct size is a more reliable endpoint than functional recovery.
Lochner A; Genade S; Moolman JA
Basic Res Cardiol; 2003 Sep; 98(5):337-46. PubMed ID: 12955407
[TBL] [Abstract][Full Text] [Related]
13. Ischemic preconditioning, adenosine and bethanechol protect spontaneously hypertensive isolated rat hearts.
Boutros A; Wang J
J Pharmacol Exp Ther; 1995 Dec; 275(3):1148-56. PubMed ID: 8531076
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal morphine preconditioning induces cardioprotection via activation of delta, kappa, and mu opioid receptors in rats.
Li R; Wong GT; Wong TM; Zhang Y; Xia Z; Irwin MG
Anesth Analg; 2009 Jan; 108(1):23-9. PubMed ID: 19095826
[TBL] [Abstract][Full Text] [Related]
15. Hyperlipidemia attenuates the infarct size-limiting effect of ischemic preconditioning: role of matrix metalloproteinase-2 inhibition.
Giricz Z; Lalu MM; Csonka C; Bencsik P; Schulz R; Ferdinandy P
J Pharmacol Exp Ther; 2006 Jan; 316(1):154-61. PubMed ID: 16166272
[TBL] [Abstract][Full Text] [Related]
16. A "second window of protection" occurs 24 h after ischemic preconditioning in the rat heart.
Yamashita N; Hoshida S; Taniguchi N; Kuzuya T; Hori M
J Mol Cell Cardiol; 1998 Jun; 30(6):1181-9. PubMed ID: 9689592
[TBL] [Abstract][Full Text] [Related]
17. The influence of the time period between preconditioning ischemia and prolonged ischemia on myocardial protection.
Alkhulaifi AM; Pugsley WB; Yellon DM
Cardioscience; 1993 Sep; 4(3):163-9. PubMed ID: 8400024
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
[TBL] [Abstract][Full Text] [Related]
19. Effects of aging and hypertension on cerebral ischemic susceptibility: evidenced by MR diffusion-perfusion study in rat.
Lee TH; Liu HL; Yang ST; Yang JT; Yeh MY; Lin JR
Exp Neurol; 2011 Feb; 227(2):314-21. PubMed ID: 21146526
[TBL] [Abstract][Full Text] [Related]
20. Interaction between pre- and postconditioning in the in vivo rat heart.
Manintveld OC; Hekkert Mt; van der Ploeg NT; Verdouw PD; Duncker DJ
Exp Biol Med (Maywood); 2009 Nov; 234(11):1345-54. PubMed ID: 19657069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
